Sentiment-Signal
17,0
Stark Bearisch
Composite Score (0–100)
Insider (25%)
0
Keine Insider-Käufe
Institutionell (22,5%)
0
Keine neuen Positionen
Aktivist (12,5%)
0
Kein 13D/13G
Risikofreier Zins (T-Bills): 3,70% (Stand: 31.03.2026)
Score-Verlauf (90 Tage)
Kritische 8-K Meldungen
| Datum | Meldung | Schwere | Filing | Auszug |
|---|---|---|---|---|
| 17.03.2025 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensato |
| 23.07.2024 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensato |
Stammdaten
BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabilizer of transthyretin, or TTR that is in Phase 3 clinical trial for the treatment of TTR amyloidosis-cardiomyopathy, or ATTR-CM; BBP-831, a small molecule selective FGFR1-3 inhibitor, which is Phase 2 clinical trial to treat achondroplasia in pediatric patients; and BBP-631, an AAV5 gene transfer product candidate that is in Phase 2 clinical trial for the treatment of congenital adrenal hyperplasia, or CAH, driven by 21-hydroxylase deficiency, or 21OHD. The company also develops Encaleret, a small molecule antagonist of the calcium sensing receptor, or CaSR, which is in phase 2 proof-of-concept clinical trial for Autosomal Dominant Hypocalcemia Type 1, or ADH1; and BBP-711 for the treatment of hyperoxaluria, as well as patients suffering from recurrent kidney stones. In addition, it engages in developing products for Mendelian, oncology, and gene therapy diseases. BridgeBio Pharma, Inc. has license and collaboration agreements with the Leland Stanford Junior University; and The Regents of the University of California; Leidos Biomedical Research, Inc. The company was founded in 2015 and is headquartered in Palo Alto, California.
Unternehmen & Branche
| Name | BridgeBio Pharma, Inc. |
|---|---|
| Ticker | BBIO |
| CIK | 0001743881 |
| Boerse | US |
| Sektor | Healthcare |
| Industrie | Biotechnology |
| SIC | 2834 · Pharmaceutical Preparations |
Wertpapier & Kennzahlen
| CUSIP | – |
|---|---|
| ISIN | – |
| Typ | Common Stock |
| Marktkapitalisierung | 13,60 Mrd. USD |
| Beta | 1,09 |
| Dividendenrendite | 0,00 % |
Externe Quellen: SEC EDGAR » · FMP-Profil » · Yahoo Finance »
Finanzkennzahlen (SEC XBRL)
| Periode | Filing | Umsatz | Nettoergebnis | EPS | Aktiva | Eigenkapital |
|---|---|---|---|---|---|---|
| 2025-12-31 | 10-K | 502,076,000 | -3.78 | 936,025,000 | -2,086,610,000 | |
| 2025-09-30 | 10-Q | 120,700,000 | -0.95 | 998,250,000 | -1,933,070,000 | |
| 2025-06-30 | 10-Q | 110,565,000 | -0.95 | 1,080,190,000 | -1,787,860,000 | |
| 2025-03-31 | 10-Q | 116,633,000 | -0.88 | 881,638,000 | -1,648,395,000 | |
| 2024-12-31 | 10-K | 221,902,000 | -2.88 | 919,338,000 | -1,467,904,000 | |
| 2024-09-30 | 10-Q | 2,732,000 | -0.86 | 664,977,000 | -1,229,922,000 | |
| 2024-06-30 | 10-Q | 2,168,000 | -0.39 | 794,375,000 | -1,092,925,000 | |
| 2024-03-31 | 10-Q | 211,120,000 | -0.20 | 849,333,000 | -1,049,528,000 | |
| 2023-12-31 | 10-K | 9,303,000 | -3.95 | 546,380,000 | -1,354,257,000 | |
| 2023-09-30 | 10-Q | 4,091,000 | -1.08 | 655,008,000 | -1,207,543,000 | |
| 2023-06-30 | 10-Q | 1,641,000 | -0.98 | 503,661,000 | -1,362,023,000 | |
| 2023-03-31 | 10-Q | 1,826,000 | -0.92 | 625,680,000 | -1,225,665,000 | |
| 2022-12-31 | 10-K | 77,648,000 | -3.26 | 623,036,000 | -1,254,617,000 | |
| 2022-09-30 | 10-Q | 338,000 | -0.93 | 728,740,000 | -1,138,417,000 | |
| 2022-06-30 | 10-Q | 73,746,000 | -0.07 | 862,233,000 | -1,025,532,000 | |
| 2022-03-31 | 10-Q | 1,694,000 | -1.35 | 813,149,000 | -1,040,996,000 | |
| 2021-12-31 | 10-K | 69,716,000 | -3.90 | 1,012,792,000 | -870,414,000 | |
| 2021-09-30 | 10-Q | 2,344,000 | -1.06 | 781,524,000 | -743,397,000 | |
| 2021-06-30 | 10-Q | 54,024,000 | -0.66 | 1,081,486,000 | -464,294,000 | |
| 2021-03-31 | 10-Q | 462,000 | 1,093,308,000 | -395,294,000 |
Fondsaktivität (Vorquartalsvergleich)
Keine Fondsdaten für dieses Unternehmen vorhanden.
Insider-Transaktionen (12 Monate)
| Datum | Insider | Rolle | Typ | Stückzahl | Kurs | Wert (USD) | Δ | Trend |
|---|---|---|---|---|---|---|---|---|
| 2026-04-10 | Kumar Neil | Director, Officer, Chief Executive Officer | Open Market Sale | -20,000 | 74.60 | -1,492,076.00 | -46,1% | |
| 2026-04-10 | Kumar Neil | Director, Officer, Chief Executive Officer | Open Market Sale | -20,000 | 74.60 | -1,492,096.00 | -46,1% | |
| 2026-04-09 | Kumar Neil | Director, Officer, Chief Executive Officer | Open Market Sale | -7,500 | 75.55 | -566,661.00 | -17,5% | |
| 2026-04-09 | Kumar Neil | Director, Officer, Chief Executive Officer | Open Market Sale | -7,200 | 73.64 | -530,239.68 | -16,4% | |
| 2026-04-09 | Kumar Neil | Director, Officer, Chief Executive Officer | Open Market Sale | -7,072 | 73.64 | -520,801.17 | -16,1% | |
| 2026-04-09 | Kumar Neil | Director, Officer, Chief Executive Officer | Open Market Sale | -5,128 | 74.57 | -382,379.06 | -11,8% | |
| 2026-04-09 | Kumar Neil | Director, Officer, Chief Executive Officer | Open Market Sale | -5,300 | 74.60 | -395,403.32 | -12,2% | |
| 2026-04-09 | Kumar Neil | Director, Officer, Chief Executive Officer | Open Market Sale | -7,800 | 75.53 | -589,123.86 | -18,2% | |
| 2026-03-13 | Kumar Neil | Director, Officer, Chief Executive Officer | Open Market Sale | -9,759 | 69.23 | -675,567.75 | -20,9% | |
| 2026-03-13 | Kumar Neil | Director, Officer, Chief Executive Officer | Open Market Sale | -10,310 | 69.20 | -713,448.91 | -22,0% | |
| 2026-03-13 | Kumar Neil | Director, Officer, Chief Executive Officer | Open Market Sale | -10,241 | 68.39 | -700,345.12 | -21,6% | |
| 2026-03-13 | Kumar Neil | Director, Officer, Chief Executive Officer | Open Market Sale | -9,690 | 68.36 | -662,441.35 | -20,4% | |
| 2026-03-12 | Kumar Neil | Director, Officer, Chief Executive Officer | Open Market Sale | -5,363 | 69.32 | -371,750.29 | -11,5% | |
| 2026-03-12 | Kumar Neil | Director, Officer, Chief Executive Officer | Open Market Sale | -14,337 | 68.48 | -981,809.23 | -30,3% | |
| 2026-03-12 | Kumar Neil | Director, Officer, Chief Executive Officer | Open Market Sale | -13,885 | 68.47 | -950,686.51 | -29,3% | |
| 2026-03-12 | Kumar Neil | Director, Officer, Chief Executive Officer | Open Market Sale | -5,815 | 69.29 | -402,928.91 | -12,4% | |
| 2026-03-12 | Kumar Neil | Director, Officer, Chief Executive Officer | Open Market Sale | -300 | 70.15 | -21,045.00 | -0,6% | |
| 2026-03-10 | Valantine Hannah | Director | Open Market Sale | -8,671 | 72.00 | -624,312.00 | -19,3% | |
| 2026-03-04 | Ellis Andrea | Director | Open Market Sale | -64,921 | 64.87 | -4,211,301.92 | -130,0% | |
| 2026-02-27 | Valantine Hannah | Director | Open Market Sale | -10,900 | 67.84 | -739,496.33 | -22,8% | |
| 2026-02-27 | Valantine Hannah | Director | Open Market Sale | -14,584 | 67.08 | -978,284.51 | -30,2% | |
| 2026-02-26 | Apuli Maricel | Officer, Chief Accounting Officer | Open Market Sale | -2,000 | 66.00 | -132,000.00 | -4,1% | |
| 2026-02-19 | Kumar Neil | Director, Officer, Chief Executive Officer | Open Market Sale | -8,528 | 72.08 | -614,701.65 | -19,0% | |
| 2026-02-19 | Kumar Neil | Director, Officer, Chief Executive Officer | Open Market Sale | -18,923 | 71.03 | -1,344,189.63 | -41,5% | |
| 2026-02-19 | Kumar Neil | Director, Officer, Chief Executive Officer | Open Market Sale | -602 | 72.80 | -43,826.20 | -1,4% | |
| 2026-02-17 | Scott Randal W. | Director | Open Market Sale | -3,307 | 75.93 | -251,087.61 | -7,8% | |
| 2026-02-17 | Trimarchi Thomas | Officer, President and CFO | Open Market Sale | -13,400 | 74.71 | -1,001,071.12 | -30,9% | |
| 2026-02-17 | Trimarchi Thomas | Officer, President and CFO | Open Market Sale | -200 | 75.38 | -15,076.00 | -0,5% | |
| 2026-02-17 | Apuli Maricel | Officer, Chief Accounting Officer | Open Market Sale | -510 | 74.31 | -37,898.10 | -1,2% | |
| 2026-02-17 | Scott Randal W. | Director | Open Market Sale | -4,793 | 75.57 | -362,218.99 | -11,2% | |
| 2026-02-17 | Scott Randal W. | Director | Open Market Sale | -1,900 | 74.34 | -141,249.99 | -4,4% | |
| 2026-02-11 | Kumar Neil | Director, Officer, Chief Executive Officer | Open Market Sale | -3,994 | 73.25 | -292,574.48 | -9,0% | |
| 2026-02-11 | Kumar Neil | Director, Officer, Chief Executive Officer | Open Market Sale | -7,860 | 70.70 | -555,705.93 | -17,2% | |
| 2026-02-11 | Kumar Neil | Director, Officer, Chief Executive Officer | Open Market Sale | -7,806 | 70.69 | -551,795.99 | -17,0% | |
| 2026-02-11 | Kumar Neil | Director, Officer, Chief Executive Officer | Open Market Sale | -4,484 | 72.64 | -325,695.34 | -10,1% | |
| 2026-02-11 | Kumar Neil | Director, Officer, Chief Executive Officer | Open Market Sale | -4,404 | 72.65 | -319,938.27 | -9,9% | |
| 2026-02-11 | Kumar Neil | Director, Officer, Chief Executive Officer | Open Market Sale | -3,961 | 73.25 | -290,145.23 | -9,0% | |
| 2026-02-11 | Kumar Neil | Director, Officer, Chief Executive Officer | Open Market Sale | -3,775 | 71.46 | -269,754.33 | -8,3% | |
| 2026-02-11 | Kumar Neil | Director, Officer, Chief Executive Officer | Open Market Sale | -3,716 | 71.44 | -265,476.99 | -8,2% | |
| 2026-02-10 | Kumar Neil | Director, Officer, Chief Executive Officer | Open Market Sale | -5,799 | 72.28 | -419,165.06 | -12,9% | |
| 2026-02-10 | Kumar Neil | Director, Officer, Chief Executive Officer | Open Market Sale | -14,201 | 71.80 | -1,019,657.36 | -31,5% | |
| 2026-02-10 | Kumar Neil | Director, Officer, Chief Executive Officer | Open Market Sale | -14,040 | 71.80 | -1,008,006.01 | -31,1% | |
| 2026-02-10 | Kumar Neil | Director, Officer, Chief Executive Officer | Open Market Sale | -5,960 | 72.27 | -430,751.25 | -13,3% | |
| 2026-01-09 | Kumar Neil | Director, Officer, Chief Executive Officer | Open Market Sale | -6,067 | 76.53 | -464,289.31 | -14,3% | |
| 2026-01-09 | Kumar Neil | Director, Officer, Chief Executive Officer | Open Market Sale | -2,151 | 75.75 | -162,942.55 | -5,0% | |
| 2026-01-09 | Kumar Neil | Director, Officer, Chief Executive Officer | Open Market Sale | -1,855 | 78.10 | -144,881.99 | -4,5% | |
| 2026-01-09 | Kumar Neil | Director, Officer, Chief Executive Officer | Open Market Sale | -375 | 78.19 | -29,322.00 | -0,9% | |
| 2026-01-09 | Kumar Neil | Director, Officer, Chief Executive Officer | Open Market Sale | -1,401 | 75.61 | -105,927.93 | -3,3% | |
| 2026-01-09 | Kumar Neil | Director, Officer, Chief Executive Officer | Open Market Sale | -10,677 | 77.46 | -827,015.86 | -25,5% | |
| 2026-01-09 | Kumar Neil | Director, Officer, Chief Executive Officer | Open Market Sale | -10,519 | 77.61 | -816,364.86 | -25,2% | |
| 2026-01-09 | Kumar Neil | Director, Officer, Chief Executive Officer | Open Market Sale | -6,955 | 76.72 | -533,568.82 | -16,5% | |
| 2026-01-08 | Kumar Neil | Director, Officer, Chief Executive Officer | Open Market Sale | -8,135 | 74.38 | -605,060.96 | -18,7% | |
| 2026-01-08 | Kumar Neil | Director, Officer, Chief Executive Officer | Open Market Sale | -11,565 | 73.65 | -851,810.82 | -26,3% | |
| 2026-01-08 | Kumar Neil | Director, Officer, Chief Executive Officer | Open Market Sale | -11,515 | 73.64 | -848,017.57 | -26,2% | |
| 2026-01-08 | Kumar Neil | Director, Officer, Chief Executive Officer | Open Market Sale | -8,085 | 74.38 | -601,340.47 | -18,6% | |
| 2026-01-08 | Kumar Neil | Director, Officer, Chief Executive Officer | Open Market Sale | -400 | 75.16 | -30,064.08 | -0,9% | |
| 2026-01-08 | Kumar Neil | Director, Officer, Chief Executive Officer | Open Market Sale | -300 | 75.20 | -22,560.99 | -0,7% | |
| 2025-12-15 | Kumar Neil | Director, Officer, Chief Executive Officer | Open Market Sale | -1,700 | 75.24 | -127,910.04 | -3,9% | |
| 2025-12-15 | Kumar Neil | Director, Officer, Chief Executive Officer | Open Market Sale | -28,311 | 74.60 | -2,111,992.11 | -65,2% | |
| 2025-12-08 | Apuli Maricel | Officer, Chief Accounting Officer | Open Market Sale | -2,000 | 74.26 | -148,520.00 | -4,6% | |
| 2025-12-05 | Kumar Neil | Director, Officer, Chief Executive Officer | Open Market Sale | -7,483 | 73.76 | -551,951.32 | -17,0% | |
| 2025-12-05 | Kumar Neil | Director, Officer, Chief Executive Officer | Open Market Sale | -12,517 | 73.05 | -914,324.29 | -28,2% | |
| 2025-12-05 | Kumar Neil | Director, Officer, Chief Executive Officer | Open Market Sale | -12,288 | 73.04 | -897,529.04 | -27,7% | |
| 2025-12-05 | Kumar Neil | Director, Officer, Chief Executive Officer | Open Market Sale | -7,712 | 73.75 | -568,758.46 | -17,6% | |
| 2025-12-04 | Kumar Neil | Director, Officer, Chief Executive Officer | Open Market Sale | -5,700 | 74.80 | -426,357.72 | -13,2% | |
| 2025-12-04 | Kumar Neil | Director, Officer, Chief Executive Officer | Open Market Sale | -12,200 | 74.42 | -907,970.36 | -28,0% | |
| 2025-12-04 | Kumar Neil | Director, Officer, Chief Executive Officer | Open Market Sale | -12,192 | 74.42 | -907,381.07 | -28,0% | |
| 2025-12-04 | Kumar Neil | Director, Officer, Chief Executive Officer | Open Market Sale | -2,100 | 73.16 | -153,626.34 | -4,7% | |
| 2025-12-04 | Kumar Neil | Director, Officer, Chief Executive Officer | Open Market Sale | -5,708 | 74.80 | -426,938.99 | -13,2% | |
| 2025-12-04 | Kumar Neil | Director, Officer, Chief Executive Officer | Open Market Sale | -2,100 | 73.16 | -153,638.31 | -4,7% | |
| 2025-11-20 | Kumar Neil | Director, Officer, Chief Executive Officer | Open Market Sale | -14,299 | 65.90 | -942,361.30 | -29,1% | |
| 2025-11-20 | Kumar Neil | Director, Officer, Chief Executive Officer | Open Market Sale | -5,456 | 66.71 | -363,985.58 | -11,2% | |
| 2025-11-20 | Kumar Neil | Director, Officer, Chief Executive Officer | Open Market Sale | -6,401 | 64.97 | -415,876.81 | -12,8% | |
| 2025-11-18 | Lo Andrew | Director | Open Market Sale | -24,007 | 65.23 | -1,566,012.62 | -48,3% | |
| 2025-11-18 | Lo Andrew | Director | Open Market Sale | -30,993 | 66.05 | -2,047,056.66 | -63,2% | |
| 2025-11-17 | Scott Randal W. | Director | Open Market Sale | -6,199 | 66.89 | -414,656.07 | -12,8% | |
| 2025-11-17 | Lo Andrew | Director | Open Market Sale | -36,801 | 66.63 | -2,451,914.47 | -75,7% | |
| 2025-11-17 | Lo Andrew | Director | Open Market Sale | -3,798 | 67.06 | -254,678.69 | -7,9% | |
| 2025-11-17 | Trimarchi Thomas | Officer, President and CFO | Open Market Sale | -6,956 | 66.84 | -464,937.65 | -14,4% | |
| 2025-11-17 | Scott Randal W. | Director | Open Market Sale | -3,801 | 66.25 | -251,809.03 | -7,8% | |
| 2025-11-17 | Trimarchi Thomas | Officer, President and CFO | Open Market Sale | -9,978 | 66.19 | -660,466.77 | -20,4% | |
| 2025-11-12 | Valantine Hannah | Director | Open Market Sale | -25,484 | 66.07 | -1,683,727.88 | -52,0% | |
| 2025-11-07 | Kumar Neil | Director, Officer, Chief Executive Officer | Open Market Sale | -220 | 62.79 | -13,814.59 | -0,4% | |
| 2025-11-07 | Kumar Neil | Director, Officer, Chief Executive Officer | Open Market Sale | -12,492 | 61.14 | -763,762.13 | -23,6% | |
| 2025-11-07 | Kumar Neil | Director, Officer, Chief Executive Officer | Open Market Sale | -12,234 | 61.13 | -747,861.97 | -23,1% | |
| 2025-11-07 | Kumar Neil | Director, Officer, Chief Executive Officer | Open Market Sale | -7,546 | 61.87 | -466,838.57 | -14,4% | |
| 2025-11-07 | Kumar Neil | Director, Officer, Chief Executive Officer | Open Market Sale | -7,308 | 61.87 | -452,156.19 | -14,0% | |
| 2025-11-07 | Kumar Neil | Director, Officer, Chief Executive Officer | Open Market Sale | -200 | 62.81 | -12,561.00 | -0,4% | |
| 2025-11-06 | Kumar Neil | Director, Officer, Chief Executive Officer | Open Market Sale | -100 | 64.39 | -6,439.00 | -0,2% | |
| 2025-11-06 | Kumar Neil | Director, Officer, Chief Executive Officer | Open Market Sale | -12,576 | 62.91 | -791,166.22 | -24,4% | |
| 2025-11-06 | Kumar Neil | Director, Officer, Chief Executive Officer | Open Market Sale | -12,529 | 62.91 | -788,184.36 | -24,3% | |
| 2025-11-06 | Kumar Neil | Director, Officer, Chief Executive Officer | Open Market Sale | -7,371 | 63.56 | -468,472.01 | -14,5% | |
| 2025-11-06 | Kumar Neil | Director, Officer, Chief Executive Officer | Open Market Sale | -7,324 | 63.55 | -465,416.03 | -14,4% | |
| 2025-11-06 | DANIELS RONALD J | Director | Open Market Sale | -61,031 | 63.72 | -3,888,999.07 | -120,1% | |
| 2025-10-29 | MCCORMICK FRANK | Director | Open Market Sale | -8,598 | 68.50 | -588,985.35 | -18,2% | |
| 2025-10-29 | MCCORMICK FRANK | Director | Open Market Sale | -111,755 | 65.48 | -7,317,315.08 | -225,9% | |
| 2025-10-29 | MCCORMICK FRANK | Director | Open Market Sale | -43,393 | 69.24 | -3,004,349.07 | -92,7% | |
| 2025-10-29 | MCCORMICK FRANK | Director | Open Market Sale | -31,116 | 66.20 | -2,059,748.51 | -63,6% | |
| 2025-10-29 | MCCORMICK FRANK | Director | Open Market Sale | -3,497 | 67.52 | -236,129.68 | -7,3% | |
| 2025-10-27 | MCCORMICK FRANK | Director | Open Market Sale | -1,641 | 65.00 | -106,665.00 | -3,3% | |
| 2025-10-09 | Kumar Neil | Director, Officer, Chief Executive Officer | Open Market Sale | -20,000 | 54.80 | -1,096,046.00 | -33,8% | |
| 2025-10-08 | Kumar Neil | Director, Officer, Chief Executive Officer | Open Market Sale | -8,706 | 54.39 | -473,503.67 | -14,6% | |
| 2025-10-08 | Kumar Neil | Director, Officer, Chief Executive Officer | Open Market Sale | -11,295 | 55.09 | -622,225.74 | -19,2% | |
| 2025-10-08 | Kumar Neil | Director, Officer, Chief Executive Officer | Open Market Sale | -11,294 | 55.09 | -622,170.65 | -19,2% | |
| 2025-10-08 | Kumar Neil | Director, Officer, Chief Executive Officer | Open Market Sale | -8,705 | 54.39 | -473,450.15 | -14,6% | |
| 2025-09-05 | Kumar Neil | Director, Officer, Chief Executive Officer | Open Market Sale | -800 | 53.80 | -43,039.52 | -1,3% | |
| 2025-09-05 | MCCORMICK FRANK | Director | Open Market Sale | -74,000 | 53.16 | -3,933,544.00 | -121,4% | |
| 2025-09-05 | Kumar Neil | Director, Officer, Chief Executive Officer | Open Market Sale | -16,900 | 53.16 | -898,449.63 | -27,7% | |
| 2025-09-05 | Kumar Neil | Director, Officer, Chief Executive Officer | Open Market Sale | -16,800 | 53.16 | -893,124.96 | -27,6% | |
| 2025-09-05 | Kumar Neil | Director, Officer, Chief Executive Officer | Open Market Sale | -2,300 | 51.96 | -119,513.75 | -3,7% | |
| 2025-09-05 | Kumar Neil | Director, Officer, Chief Executive Officer | Open Market Sale | -2,300 | 51.95 | -119,495.58 | -3,7% | |
| 2025-09-05 | Kumar Neil | Director, Officer, Chief Executive Officer | Open Market Sale | -900 | 53.80 | -48,423.96 | -1,5% | |
| 2025-09-04 | Kumar Neil | Director, Officer, Chief Executive Officer | Open Market Sale | -5,475 | 51.85 | -283,902.29 | -8,8% | |
| 2025-09-04 | Kumar Neil | Director, Officer, Chief Executive Officer | Open Market Sale | -14,558 | 51.16 | -744,739.24 | -23,0% | |
| 2025-09-04 | Kumar Neil | Director, Officer, Chief Executive Officer | Open Market Sale | -14,525 | 51.15 | -742,959.56 | -22,9% | |
| 2025-09-04 | Kumar Neil | Director, Officer, Chief Executive Officer | Open Market Sale | -5,442 | 51.85 | -282,186.75 | -8,7% | |
| 2025-08-21 | Trimarchi Thomas | Officer, President and CFO | Open Market Sale | -42,237 | 49.48 | -2,090,081.05 | -64,5% | |
| 2025-08-20 | Kumar Neil | Director, Officer, Chief Executive Officer | Open Market Sale | -428 | 49.25 | -21,079.17 | -0,7% | |
| 2025-08-20 | Kumar Neil | Director, Officer, Chief Executive Officer | Open Market Sale | -25,728 | 48.81 | -1,255,848.00 | -38,8% | |
| 2025-08-18 | Trimarchi Thomas | Officer, President and CFO | Open Market Sale | -1,973 | 50.94 | -100,512.31 | -3,1% | |
| 2025-08-18 | Trimarchi Thomas | Officer, President and CFO | Open Market Sale | -15,380 | 50.14 | -771,210.11 | -23,8% | |
| 2025-08-11 | HOMCY CHARLES J | Director | Open Market Sale | -50,000 | 48.00 | -2,400,000.00 | -74,1% | |
| 2025-08-08 | Kumar Neil | Director, Officer, Chief Executive Officer | Open Market Sale | -11,795 | 45.88 | -541,161.68 | -16,7% | |
| 2025-08-08 | HOMCY CHARLES J | Director | Open Market Sale | -191,662 | 45.87 | -8,791,593.44 | -271,4% | |
| 2025-08-08 | HOMCY CHARLES J | Director | Open Market Sale | -58,338 | 46.64 | -2,720,849.32 | -84,0% | |
| 2025-08-08 | Kumar Neil | Director, Officer, Chief Executive Officer | Open Market Sale | -8,205 | 46.71 | -383,252.27 | -11,8% | |
| 2025-08-07 | Apuli Maricel | Officer, Chief Accounting Officer | Open Market Sale | -1,000 | 45.44 | -45,440.00 | -1,4% | |
| 2025-08-07 | Kumar Neil | Director, Officer, Chief Executive Officer | Open Market Sale | -13,216 | 45.64 | -603,151.81 | -18,6% | |
| 2025-08-07 | Kumar Neil | Director, Officer, Chief Executive Officer | Open Market Sale | -6,784 | 45.09 | -305,908.88 | -9,4% | |
| 2025-08-05 | Ellis Andrea | Director | Open Market Sale | -17,167 | 49.00 | -841,183.00 | -26,0% | |
| 2025-07-02 | Kumar Neil | Director, Officer, Chief Executive Officer | Open Market Sale | -20,000 | 42.73 | -854,536.00 | -26,4% | |
| 2025-07-02 | Kumar Neil | Director, Officer, Chief Executive Officer | Open Market Sale | -20,000 | 42.73 | -854,514.00 | -26,4% | |
| 2025-07-01 | Kumar Neil | Director, Officer, Chief Executive Officer | Open Market Sale | -1,600 | 42.89 | -68,628.00 | -2,1% | |
| 2025-07-01 | Kumar Neil | Director, Officer, Chief Executive Officer | Open Market Sale | -18,400 | 42.51 | -782,092.00 | -24,1% | |
| 2025-07-01 | Kumar Neil | Director, Officer, Chief Executive Officer | Open Market Sale | -18,300 | 42.50 | -777,777.45 | -24,0% | |
| 2025-07-01 | Kumar Neil | Director, Officer, Chief Executive Officer | Open Market Sale | -1,700 | 42.88 | -72,902.97 | -2,3% | |
| 2025-06-27 | VIKING GLOBAL INVESTORS LP | 10% Owner | Open Market Sale | -3,500,000 | 44.00 | -154,000,000.00 | -4753,9% | |
| 2025-06-26 | Valantine Hannah | Director | Open Market Sale | -398 | 44.13 | -17,562.27 | -0,5% | |
| 2025-06-26 | Valantine Hannah | Director | Open Market Sale | -1,891 | 44.03 | -83,261.30 | -2,6% | |
| 2025-06-26 | Valantine Hannah | Director | Open Market Sale | -1,542 | 44.01 | -67,863.42 | -2,1% | |
| 2025-06-26 | Valantine Hannah | Director | Open Market Sale | -876 | 44.11 | -38,640.27 | -1,2% | |
| 2025-06-24 | MCCORMICK FRANK | Director | Open Market Sale | -100,000 | 44.23 | -4,422,800.00 | -136,5% | |
| 2025-06-10 | Valantine Hannah | Director | Open Market Sale | -4,292 | 40.00 | -171,680.00 | -5,3% | |
| 2025-05-20 | Kumar Neil | Director, Officer, Chief Executive Officer | Open Market Sale | -75,000 | 33.40 | -2,504,977.50 | -77,3% | |
| 2025-05-19 | Kumar Neil | Director, Officer, Chief Executive Officer | Open Market Sale | -400 | 33.75 | -13,499.00 | -0,4% | |
| 2025-05-19 | Kumar Neil | Director, Officer, Chief Executive Officer | Open Market Sale | -25,756 | 33.32 | -858,264.61 | -26,5% | |
| 2025-05-12 | KKR Genetic Disorder L.P. | 10% Owner | Open Market Sale | -6,000,000 | 34.20 | -205,200,000.00 | -6334,4% | |
| 2025-05-02 | Apuli Maricel | Officer, Chief Accounting Officer | Open Market Sale | -1,026 | 38.51 | -39,509.11 | -1,2% | |
| 2025-05-02 | Lo Andrew | Director | Open Market Sale | -100,000 | 38.50 | -3,849,900.00 | -118,8% |
Top-Fondshalter
Keine Fondsdaten zu dieser Aktie vorhanden.